← All Topics / ade

FDA ADE reports for Emodepside (cyclo-octadepsipeptide anthelmintic (tapeworm, cats)) — total reports, species & reaction breakdown

ade_emodepside_adverse_events

ade en 2026-07-22

Emodepside — FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Emodepside is a cyclo-octadepsipeptide anthelmintic (tapeworm, cats).

Total reports

Emodepside: 4964

Reports by species (top entries)

  • Cat 4612
  • Human 73
  • Dog 36
  • Rabbit 1
  • Whale 1

Top reported reactions (VEDDRA terms, top entries)

  • Application site alopecia 1121
  • Hypersalivation 827
  • Lethargy (see also Central nervous system depression in 'Neurological') 649
  • Vomiting 462
  • Ataxia 384
  • Lack of efficacy (endoparasite) - tapeworm 376
  • Behavioural disorder NOS 337
  • Anorexia 299
  • Application site erythema 266
  • Application site pruritus 264

"Lack of efficacy" terms denote product-performance reports, not adverse reactions.

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b8.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).

Sources

  • openFDA animalandveterinary/event.json (FDA CVM ADE), pulled 2026-07-22